(Q51492603)

5 April 2018

title

APOL1 variants and kidney disease in people of recent African ancestry. (English)

1 reference

5 April 2018

1 reference

Giulio Genovese

1

1 reference

5 April 2018

David J Friedman

series ordinal

2

1 reference

5 April 2018

Martin R Pollak

series ordinal

3

1 reference

5 April 2018

language of work or name

English

0 references

publication date

26 February 2013

1 reference

5 April 2018

Nature Reviews Nephrology

published in

1 reference

5 April 2018

volume

9

1 reference

5 April 2018

issue

4

1 reference

5 April 2018

page(s)

240-244

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1038/nrneph.2013.34

exact match

0 references

cites work

Race, socioeconomic status, and the development of end-stage renal disease

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

MYH9 is associated with nondiabetic end-stage renal disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are strongly associated with end-stage renal disease historically attributed to hypertension in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Non-muscle myosin heavy chain 9 gene MYH9 associations in African Americans with clinically diagnosed type 2 diabetes mellitus-associated ESRD

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: the HyperGEN study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

African ancestry allelic variation at the MYH9 gene contributes to increased susceptibility to non-diabetic end-stage kidney disease in Hispanic Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Dense mapping of MYH9 localizes the strongest kidney disease associations to the region of introns 13 to 15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

The association of the MYH9 gene and kidney outcomes in American Indians: the Strong Heart Family Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

A second generation human haplotype map of over 3.1 million SNPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Whole-genome patterns of common DNA variation in three human populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

A DNA Polymorphism Discovery Resource for Research on Human Genetic Variation: Table 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Ascertainment bias in studies of human genome-wide polymorphism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

A map of human genome variation from population-scale sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Association of trypanolytic ApoL1 variants with kidney disease in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

The APOL1 gene and allograft survival after kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

APOL1 variants increase risk for FSGS and HIVAN but not IgA nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Genetic variation in APOL1 associates with younger age at hemodialysis initiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Population-based risk assessment of APOL1 on renal disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

APOL1 localization in normal kidney and nondiabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

A common sequence motif associated with recombination hot spots and genome instability in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Reduced neutrophil count in people of African descent is due to a regulatory variant in the Duffy antigen receptor for chemokines gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Discovery and genotyping of genome structural polymorphism by sequencing on a population scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

A High-Density Admixture Map for Disease Gene Discovery in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

A risk allele for focal segmental glomerulosclerosis in African Americans is located within a region containing APOL1 and MYH9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

MYH9 and APOL1 are both associated with sickle cell disease nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Absence of APOL1 risk variants protects against HIV-associated nephropathy in the Ethiopian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Genetic testing in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

The population genetics of chronic kidney disease: insights from the MYH9-APOL1 locus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

The new era of APOL1-associated glomerulosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Genetic association and gene-gene interaction analyses in African American dialysis patients with nondiabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

APOL1 allelic variants are associated with lower age of dialysis initiation and thereby increased dialysis vintage in African and Hispanic Americans with non-diabetic end-stage kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with the progression of IgA nephropathy in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

The MYH9/APOL1 region and chronic kidney disease in European-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Polymorphisms in MYH9 are associated with diabetic nephropathy in European Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Differential effects of MYH9 and APOL1 risk variants on FRMD3 Association with Diabetic ESRD in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2013.34

A DNA polymorphism discovery resource for research on human genetic variation

31 March 2020

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23438974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Expression of the nonmuscle myosin heavy chain IIA in the human kidney and screening for MYH9 mutations in Epstein and Fechtner syndromes

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23438974

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NRNEPH.2013.34

1 reference

5 April 2018

Dimensions Publication ID

0 references

1 reference

5 April 2018